Osborne Clarke advised Earlybird, Merieux Equity Partners and NRW.BANK on the deal. Prothea Technologies (Prothea), a private medical technology company spun-out of the Universities of Edinburgh...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Riverlane on the deal. Riverlane, the global leader in quantum error correction (QEC) technology, completed its US$75 million Series C funding round to...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised OXCCU on the fundraising. OXCCU announced its $22.7 million (£18 million) Series A fundraising round to commercialise cost-effective sustainable aviation fuel (SAF). The Series...
You must be a Standard 1 Year member to access this content.
Withers tech advised Edenred Capital Partners on the deal. Osborne Clarke advised AlbionVC. Edenred Capital Partners invested into 5Mins AI, a microlearning platform that helps employees...
You must be a Standard 1 Year member to access this content.
Latham & Watkins has advised Intuitive Ventures on the deal. Osborne Clarke has advised Optellum. Higgs LLP advised Mercia. Optellum executed its US$14 million Series A funding...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Toqio on the deal. Osborne Clarke advised AlbionVC. The fast-growing fintech SaaS provider Toqio closed its €18.7 million Series A funding round....
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Nexeon on the deal. Nexeon made a total investment of US$170 million and a further US$50 million of commercial investments made in...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Nexeon on the deal. Nexeon was granted significant US$80 million investment from a consortium including SKC Co. Ltd (SKC), SJL Partners LLC...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised NeRRe Therapeutics on the deal. The financing involved a syndicate of leading transatlantic life sciences investors led by new investor Columbus Venture Partners...
You must be a Standard 1 Year member to access this content.
